Salicylic acid 2% in Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salicylic acid 2% in betamethasone valerate 0.1% ointment

special order - betamethasone valerate; salicylic acid - ointment - 980microgram/1gram ; 20mg/1gram

BETAMETHASONE VALERATE aerosol, foam United States - English - NLM (National Library of Medicine)

betamethasone valerate aerosol, foam

mylan pharmaceuticals inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - betamethasone valerate foam is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. betamethasone valerate foam is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation.

BETAMETHASONE VALERATE aerosol, foam United States - English - NLM (National Library of Medicine)

betamethasone valerate aerosol, foam

taro pharmaceuticals u.s.a., inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. betamethasone valerate foam, 0.12% is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation.

BETAMETHASONE VALERATE aerosol, foam United States - English - NLM (National Library of Medicine)

betamethasone valerate aerosol, foam

ingenus pharmaceuticals, llc - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. betamethasone valerate foam, 0.12% is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation.

BETAMETHASONE VALERATE aerosol, foam United States - English - NLM (National Library of Medicine)

betamethasone valerate aerosol, foam

padagis israel pharmaceuticals ltd - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp. betamethasone valerate foam, 0.12% is contraindicated in patients who are hypersensitive to betamethasone valerate, to other corticosteroids, or to any ingredient in this preparation.

BETAMETHASONE VALERATE cream United States - English - NLM (National Library of Medicine)

betamethasone valerate cream

rebel distributors corp. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1 mg in 1 g - betamethasone valerate cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. betamethasone valerate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Salicylic acid 5% in Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salicylic acid 5% in betamethasone valerate 0.1% ointment

special order - salicylic acid; betamethasone valerate - ointment - 50mg/1gram ; 950microgram/1gram

Coal tar solution 5% / Salicylic acid 10% in Betamethasone valerate 0.025% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 5% / salicylic acid 10% in betamethasone valerate 0.025% ointment

special order - betamethasone valerate; salicylic acid; coal tar solution - ointment - 212.5microgram/1gram ; 100mg/1gram ; 50mg/1gram

Coal tar solution 10% / Salicylic acid 2% in Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 10% / salicylic acid 2% in betamethasone valerate 0.1% ointment

special order - salicylic acid; coal tar solution; betamethasone valerate - ointment - 20mg/1gram ; 100mg/1gram ; 880microgram/1gram

Coal tar solution 10% / Salicylic acid 5% in Betamethasone valerate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coal tar solution 10% / salicylic acid 5% in betamethasone valerate 0.1% ointment

special order - salicylic acid; coal tar solution; betamethasone valerate - ointment - 50mg/1gram ; 100mg/1gram ; 850microgram/1gram